Itai Yanai and Martin Lercher Launch the Night Science Institute
Night Science Institute shared a post on LinkedIn:
“Today, we are announcing the launch of the Night Science Institute by our Founders, Dr. Itai Yanai and Dr. Martin Lercher!
The Institute champions a cultural shift in science by training researchers to embrace the creative Night Science process as an essential complement to rigorous hypothesis testing.
We are thrilled to have Gretchen E. Vaughan, President and CEO of the Kidney Cancer Association, join our board, bringing her extensive experience in running a successful non-profit to our startup.
We are proud to have Dr. Oliver Bogler as our CEO, who comes with an extensive track record in cancer research and academic leadership, most recently at the National Cancer Institute (NCI).
Our advisory board includes Dr. Tina Seelig, Dr. Jennifer Oyler-Yaniv, and Dr. Sean B. Carroll, all experts in scientific creativity and strong supporters of Night Science.
Check out our website and please watch Itai and Martin explain their vision for the Institute in this video:”
Gretchen E. Vaughan, CEO of Kidney Cancer Association, shared this post, adding:
“I’m so honored to be able to support this incredibly committed and brilliant team in further support of the scientific community as a whole. Come join in the fun!”
Proceed to the video attached to the post.
More posts featuring Itai Yanai and Martin Lercher on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023